BUSINESS COMBINATION (Details 2) (USD $)	Jun. 19, 2013
Fair value of BioSante shares outstanding	$ 29,795,133
Estimated fair value of vested BioSante stock options	0
Total purchase consideration	29,795,133
Assets acquired
Cash and cash equivalents	18,197,442
Restricted cash	2,260,100
Teva license intangible asset	10,900,000
Other tangible assets	79,261
Deferred tax assets, net	0
Goodwill	1,838,309
Total assets	33,275,112
Liabilities assumed
Accrued severance	2,964,962
Other liabilities	515,017
Total liabilities	3,479,979
Total net assets acquired	$ 29,795,133